These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6295268)

  • 21. Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep.
    Guerrini VH; Filippich LJ; Cao GR; English PB; Bourne DW
    J Vet Pharmacol Ther; 1985 Jun; 8(2):120-7. PubMed ID: 4020943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic profile of ceftriaxone in man.
    Patel IH; Kaplan SA
    Am J Med; 1984 Oct; 77(4C):17-25. PubMed ID: 6093513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.
    Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.
    Fourtillan JB; Bryskier A; Mignot A; Borsa F; Humbert G
    Am J Med; 1984 Dec; 77(6A):28-31. PubMed ID: 6097120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose pharmacokinetics of ceftriaxone in patients with end-stage renal disease and hemodialysis.
    Losno Garcia R; Santivañez V; Battilana CA
    Chemotherapy; 1988; 34(4):261-6. PubMed ID: 3208543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology of ceftriaxone in patients with neoplastic disease.
    Salvador P; Smith RG; Weinfeld RE; Ellis DH; Bodey GP
    Antimicrob Agents Chemother; 1983 Apr; 23(4):583-8. PubMed ID: 6305263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftriaxone levels in blood and tissue during cardiopulmonary bypass surgery.
    Bryan CS; Morgan SL; Jordan AB; Smith CW; Sutton JP; Gangemi JD
    Antimicrob Agents Chemother; 1984 Jan; 25(1):37-9. PubMed ID: 6322680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fundamental study on ceftriaxone].
    Kawakita K; Ide T; Urabe M; Miyazaki H; Ono S; Yamasaki K; Morita I; Sato M; Kawazoe T
    Jpn J Antibiot; 1984 Jun; 37(6):1029-34. PubMed ID: 6092736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis.
    Ti TY; Fortin L; Kreeft JH; East DS; Ogilvie RI; Somerville PJ
    Antimicrob Agents Chemother; 1984 Jan; 25(1):83-7. PubMed ID: 6322683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
    Kowalsky SF; Echols RM; Parker MA
    Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis.
    Cohen D; Appel GB; Scully B; Neu HC
    Antimicrob Agents Chemother; 1983 Oct; 24(4):529-32. PubMed ID: 6316845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pharmacokinetic and tolerance study of Ro13-9904, a new cephalosporin antibiotic.
    Pickup ME; Bird HA; Lowe JR; Lees L; Wright V
    Br J Clin Pharmacol; 1981 Aug; 12(2):111-5. PubMed ID: 6272830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftriaxone pharmacokinetics in newborn infants.
    McCracken GH; Siegel JD; Threlkeld N; Thomas M
    Antimicrob Agents Chemother; 1983 Feb; 23(2):341-3. PubMed ID: 6301369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model.
    Stoeckel K; Koup JR
    Am J Med; 1984 Oct; 77(4C):26-32. PubMed ID: 6093514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cefotiam in humans.
    Rouan MC; Lecaillon JB; Guibert J; Modai J; Schoeller JP
    Antimicrob Agents Chemother; 1985 Feb; 27(2):177-80. PubMed ID: 3857018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.
    Lenfant B; Namour F; Logeais C; Coussediere D; Rivault O; Bryskier A; Surjus A
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2037-41. PubMed ID: 8540712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics and clinical studies on ceftriaxone in the field of obstetrics and gynecology].
    Cho N; Watanabe H; Yoshida K; Moriyama S; Takeda H; Tsukamoto A; Fukunaga K; Kunii K; Komoriyama Y
    Jpn J Antibiot; 1984 Dec; 37(12):2304-19. PubMed ID: 6098723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftriaxone therapy of serious bacterial infections in adults.
    Bittner MJ; Dworzack DL; Preheim LC; Tofte RW; Crossley KB
    Antimicrob Agents Chemother; 1983 Feb; 23(2):261-6. PubMed ID: 6301365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
    Nahata MC; Durrell DE; Barson WJ
    Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves.
    Dardi MS; Sharma SK; Srivastava AK
    Vet Res Commun; 2004 May; 28(4):331-8. PubMed ID: 15222737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.